Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1492144986;44987;44988 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
N2AB1328040063;40064;40065 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
N2A1235337282;37283;37284 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
N2B585617791;17792;17793 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
Novex-1598118166;18167;18168 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
Novex-2604818367;18368;18369 chr2:178624519;178624518;178624517chr2:179489246;179489245;179489244
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Ig-100
  • Domain position: 69
  • Structural Position: 153
  • Q(SASA): 0.3656
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs776808932 None 0.627 N 0.537 0.287 0.295974979623 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
T/I rs776808932 None 0.627 N 0.537 0.287 0.295974979623 gnomAD-4.0.0 2.73851E-06 None None None None N None 2.99401E-05 0 None 0 0 None 0 0 8.99909E-07 2.31959E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1264 likely_benign 0.1067 benign -1.043 Destabilizing 0.001 N 0.207 neutral N 0.508332558 None None N
T/C 0.6727 likely_pathogenic 0.6261 pathogenic -0.736 Destabilizing 0.944 D 0.511 neutral None None None None N
T/D 0.4871 ambiguous 0.4649 ambiguous -1.027 Destabilizing 0.241 N 0.51 neutral None None None None N
T/E 0.3125 likely_benign 0.3311 benign -0.998 Destabilizing 0.241 N 0.481 neutral None None None None N
T/F 0.4543 ambiguous 0.3908 ambiguous -1.186 Destabilizing 0.818 D 0.578 neutral None None None None N
T/G 0.4147 ambiguous 0.3773 ambiguous -1.321 Destabilizing 0.241 N 0.53 neutral None None None None N
T/H 0.3703 ambiguous 0.3774 ambiguous -1.678 Destabilizing 0.818 D 0.567 neutral None None None None N
T/I 0.1868 likely_benign 0.1962 benign -0.379 Destabilizing 0.627 D 0.537 neutral N 0.501928201 None None N
T/K 0.1573 likely_benign 0.2774 benign -0.898 Destabilizing 0.001 N 0.292 neutral N 0.492753553 None None N
T/L 0.159 likely_benign 0.1356 benign -0.379 Destabilizing 0.241 N 0.496 neutral None None None None N
T/M 0.1093 likely_benign 0.0934 benign 0.083 Stabilizing 0.981 D 0.506 neutral None None None None N
T/N 0.1719 likely_benign 0.1348 benign -1.047 Destabilizing 0.019 N 0.252 neutral None None None None N
T/P 0.1837 likely_benign 0.1801 benign -0.569 Destabilizing 0.773 D 0.537 neutral D 0.548472214 None None N
T/Q 0.2084 likely_benign 0.2657 benign -1.23 Destabilizing 0.527 D 0.533 neutral None None None None N
T/R 0.1836 likely_benign 0.2377 benign -0.666 Destabilizing 0.003 N 0.287 neutral N 0.506813916 None None N
T/S 0.2166 likely_benign 0.1667 benign -1.252 Destabilizing 0.09 N 0.523 neutral N 0.507714891 None None N
T/V 0.1928 likely_benign 0.1772 benign -0.569 Destabilizing 0.241 N 0.447 neutral None None None None N
T/W 0.7052 likely_pathogenic 0.7185 pathogenic -1.14 Destabilizing 0.981 D 0.606 neutral None None None None N
T/Y 0.4302 ambiguous 0.3799 ambiguous -0.873 Destabilizing 0.818 D 0.578 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.